Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Mediphage Bioceuticals

Mediphage Bioceuticals is a company developing cures to diseases founded in 2016 by Roderick Slavcev.

Overview Structured Data Issues Contributors Activity

Is a

Company attributes

Industry

Biomedical engineering

Location

B2X

CEO

Founder

AngelList URL

angel.co/mediphage-...ioceuticals

Number of Employees (Ranges)

11 – 500

Full Address

661 University Avenue Suite 1300 Toronto, Ontario M5G 0B7 Canada0

Investors

Wing Venture Capital

‌

Family Office (2)

Viking Global Investors

Founded Date

2016

Total Funding Amount (USD)

4,146,000

Latest Funding Round Date

March 2019

Latest Funding Type

Seed

Patents Assigned (Count)

Wellfound ID

mediphage-bioceuticals

Country

Canada

Other attributes

Company Operating Status

Active

Mediphage Bioceuticals is a non-viral gene therapy company focused on developing gene therapies for patients worldwide. The company's flagship technology, ministring DNA, is a form of non-viral transgene delivery.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Mediphage Bioceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.